Skip to main content
. 2019 Jan-Feb;9(1):72–83.

Table 1.

Nody weight, blood glucose levels, and levels of liver damage parameters (ALT, AST and total protein serum) in Z. multiflora-treated and control groups, at the end of study

Group Weight
(g)
Glucose
(mg/dl)
Insulin
(ng/ml)
ALT
(IU/ml)
AST
(IU/ml)
Total protein
(mg/ml)
control 318.7±5.3a 82.3 ±2.6a 1.44±0.18 a 59.3±4.22 a 135.6±11.5a 72.1±1.0a
STZ 208.7±8.8b 483.4±18.9b 0.39±0.07 b 151.2±9.0b 296.3±20.1b 50.0 ±3.0b
STZ+Zataria250 224.6±6.3b 377.2±24.9d 0.705±0.1 b 128.8±14.4bc 277.2±7.0b 56.0±2.0b
STZ+Zataria500 227.3±7.1b 308.1±14.3cd 0.925±0.057 ab 105.3±16.5c 200.5±13. 9c 59.3±5.2b
STZ+Zataria1000 243.4±8.5b 258.3±27.2c 0.920±0.042 ab 86.0±7.0ac 186.7±18.7ac 70.0±3.0ac
Zataria1000 296.8±16.1a 77.2±2.28a 1.36±0.27 a 48.8±3.4a 131.2±14.1a 71.8±1.6a

STZ: Streptozotocin 60mg/kg; STZ+Zataria 250 mg/kg: streptozotocin+Z. multiflora 250 mg/kg; STZ+Zataria 500 mg/kg: streptozotocin+Z. multiflora 500mg/kg; STZ+Zataria 1000 mg/kg: streptozotocin+Z. multiflora 1000 mg/kg.

a, b, c, and d

: According to post-hoc Tukey test which was used for intergroup comparisons, groups with same superscripts are not significantly different at α=0.05 (p≥0.05). However, dissimilar letters indicate a significant difference (p<0.05).